Poster Session D - Tuesday Morning
Category: IBD
Jakob Begun, MD, PhD
Mater Health
South Brisbane, Queensland, Australia
Age | Gender | Treatment Dose | Day | Mayo Score | Tissue TNF-α (ng/g) | Tissue IL-6 (ng/g) | Tissue OSM (ng/g) | Fecal Calpro (µg/g) | R/NR Final Visit | |
Patient 1 | 26 | F | 160 mg | 0 | 10 | 14.9 | 40.5 | 24.6 | 1643 | |
4 | 3 | 8.1 | 10.8 | 4.6 | ||||||
8 | 1 | 4.49 | 3.4 | 4.8 | 358 | |||||
120 | 25 | R | ||||||||
Patient 2 | 28 | F | 160 mg | 0 | 4 | 2760 | ||||
2/4 | 2 | 6.68 | 35.3 | 32.2 | 235 | |||||
8 | 3 | 5.08 | 18.5 | 10.2 | R | |||||
Patient 3 | 29 | M | 160 mg | 0 | 7 | 29.8 | 9.7 | 43 | 681 | |
4 | 5 | 42.1 | 31.6 | 24 | 3143 | |||||
8 | 29.2 | 13.2 | 36.9 | 754 | ||||||
Patient 4 | 67 | F | 80 mg | 0 | 9 | 174.4 | 60.7 | 13.7 | 2432 | |
4 | 121 | 89.6 | 19 | 258 | ||||||
8 | 141 | 346 | 228 | 1834 |